Taken together, TTLshort/high-risk leukemias are characterized by highly activated constitutive mTOR signaling maintained upon ex vivo culture, in contrast to low and decreasing mTOR activity in TTLlong ALL. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.